Literature DB >> 19735096

High-intensity focused ultrasound with large scale spherical phased array for the ablation of deep tumors.

Xiang Ji1, Jing-feng Bai, Guo-feng Shen, Ya-zhu Chen.   

Abstract

Under some circumstances surgical resection is feasible in a low percentage for the treatment of deep tumors. Nevertheless, high-intensity focused ultrasound (HIFU) is beginning to offer a potential noninvasive alternative to conventional therapies for the treatment of deep tumors. In our previous study, a large scale spherical HIFU-phased array was developed to ablate deep tumors. In the current study, taking into account the required focal depth and maximum acoustic power output, 90 identical circular PZT-8 elements (diameter =1.4 cm and frequency=1 MHz) were mounted on a spherical shell with a radius of curvature of 18 cm and a diameter of 21 cm. With the developed array, computer simulations and ex vivo experiments were carried out. The simulation results theoretically demonstrate the ability of the array to focus and steer in the specified volume (a 2 cmx2 cmx3 cm volume) at the focal depth of 15 to 18 cm. Ex vivo experiment results also verify the capability of the developed array to ablate deep target tissue by either moving single focal point or generating multiple foci simultaneously.

Entities:  

Mesh:

Year:  2009        PMID: 19735096      PMCID: PMC2738833          DOI: 10.1631/jzus.B0920130

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  11 in total

1.  Theoretical design of a spherically sectioned phased array for ultrasound surgery of the liver.

Authors:  D R Daum; K Hynynen
Journal:  Eur J Ultrasound       Date:  1999-03

2.  High-intensity focused ultrasound for the treatment of liver tumours.

Authors:  J E Kennedy; F Wu; G R ter Haar; F V Gleeson; R R Phillips; M R Middleton; D Cranston
Journal:  Ultrasonics       Date:  2004-04       Impact factor: 2.890

3.  Transurethral ultrasound applicators with directional heating patterns for prostate thermal therapy: in vivo evaluation using magnetic resonance thermometry.

Authors:  C J Diederich; R J Stafford; W H Nau; E C Burdette; R E Price; J D Hazle
Journal:  Med Phys       Date:  2004-02       Impact factor: 4.071

4.  Multiple-focus ultrasound phased-array pattern synthesis: optimal driving-signal distributions for hyperthermia.

Authors:  E S Ebbini; C A Cain
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  1989       Impact factor: 2.725

5.  A 256-element ultrasonic phased array system for the treatment of large volumes of deep seated tissue.

Authors:  D R Daum; K Hynynen
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  1999       Impact factor: 2.725

6.  High power phased array prototype for clinical high intensity focused ultrasound : applications to transcostal and transcranial therapy.

Authors:  M Pernot; J -F Aubry; M Tanter; F Marquet; G Montaldo; A -L Boch; M Kujas; D Seilhean; M Fink
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2007

7.  Utility of a tumor-mimic model for the evaluation of the accuracy of HIFU treatments. results of in vitro experiments in the liver.

Authors:  William Apoutou N'Djin; David Melodelima; Hubert Parmentier; Sabrina Chesnais; Michel Rivoire; Jean Yves Chapelon
Journal:  Ultrasound Med Biol       Date:  2008-07-14       Impact factor: 2.998

8.  A spherical-section ultrasound phased array applicator for deep localized hyperthermia.

Authors:  E S Ebbini; C A Cain
Journal:  IEEE Trans Biomed Eng       Date:  1991-07       Impact factor: 4.538

9.  Image-guided 256-element phased-array focused ultrasound surgery.

Authors:  Mingzhu Lu; Xiaodong Wang; Mingxi Wan; Yi Feng; Feng Xu; Hui Zhong; Jinwen Tan
Journal:  IEEE Eng Med Biol Mag       Date:  2008 Sep-Oct

Review 10.  High-intensity focused ultrasound in the treatment of solid tumours.

Authors:  James E Kennedy
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

View more
  1 in total

Review 1.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.